Tekla Capital Management LLC Invests $316,000 in Altimmune, Inc. (NASDAQ:ALT)
Tekla Capital Management LLC acquired a new position in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 75,000 shares of the company’s stock, valued at approximately $316,000. Tekla Capital Management LLC owned approximately […]